179 related articles for article (PubMed ID: 30707471)
1. Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells.
Zhao Y; Mu Z; Cai L; Liu X; Jia J; Zhang J
Dermatol Ther; 2019 Jul; 32(4):e12849. PubMed ID: 30707471
[TBL] [Abstract][Full Text] [Related]
2. Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
Zhao Y; Wen G; Qiao Z; Xu H; Sun Q; Huang H; Shan S; Mu Z; Zhang J
Lupus; 2013 Apr; 22(5):469-76. PubMed ID: 23554035
[TBL] [Abstract][Full Text] [Related]
3. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
4. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y
Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
Liu CP; Tsai WJ; Shen CC; Lin YL; Liao JF; Chen CF; Kuo YC
Eur J Pharmacol; 2006 Feb; 531(1-3):270-9. PubMed ID: 16413531
[TBL] [Abstract][Full Text] [Related]
7. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
8. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
Wu H; Lo Y; Chan A; Law KS; Mok MY
Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
[TBL] [Abstract][Full Text] [Related]
9. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
Dai H; He F; Tsokos GC; Kyttaris VC
J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells.
Du LJ; Feng YX; He ZX; Huang L; Wang Q; Wen CP; Zhang Y
Acta Pharmacol Sin; 2022 Jun; 43(6):1521-1533. PubMed ID: 34552214
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Bobé P; Bonardelle D; Benihoud K; Opolon P; Chelbi-Alix MK
Blood; 2006 Dec; 108(13):3967-75. PubMed ID: 16926289
[TBL] [Abstract][Full Text] [Related]
13. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
14. IL-10 regulates murine lupus.
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
[TBL] [Abstract][Full Text] [Related]
15. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
Qiu F; Li T; Zhang K; Wan J; Qi X
Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
[TBL] [Abstract][Full Text] [Related]
16. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
Shui B; Xia W; Wen C; Ding X
J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
[TBL] [Abstract][Full Text] [Related]
18. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
[TBL] [Abstract][Full Text] [Related]
19. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
Zhang X; Wang G; Bi Y; Jiang Z; Wang X
Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
